In the BioHarmony Drug Report Database

"Preview" Icon

Triamcinolone hexacetonide

Aristospan (triamcinolone hexacetonide) is a small molecule pharmaceutical. Triamcinolone hexacetonide was first approved as Aristospan on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA.

 

Trade Name

 

Aristospan
 

Common Name

 

triamcinolone hexacetonide
 

ChEMBL ID

 

CHEMBL1200878
 

Indication

 

adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, berylliosis, bronchial spasm, dermatitis herpetiformis, erythema multiforme, facial dermatoses, foot dermatoses, hand dermatoses, hemolytic anemia, hypercalcemia, inflammation, leg dermatoses, multiple sclerosis, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, scalp dermatoses, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
 

Drug Class

 

Steroids (not prednisolone derivatives); topical steroids (acetal derivatives)

Image (chem structure or protein)

Triamcinolone hexacetonide structure rendering